Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

NCT06995976 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Tumour

Interventions

DRUG: 68Ga-dPNE
DRUG: 18F-FDG

Sponsor

First Affiliated Hospital of Fujian Medical University